从临床变量到多组学分析:基于边缘形态的肝癌大体分类系统用于分层
该前瞻性队列纳入400例接受肝切除术的单发肝细胞癌患者,评估基于边缘形态的大体分类与预后关系,并对49例患者肿瘤及非肿瘤组织行多组学分析。四种大体亚型3年总生存率分别为I型91%、II型80%、III型74.6%、IV型38.8%,IV型为独立不良预后因素,并表现出血管生成和免疫评分增高、代谢通路降低及TP53突变频率最高。
要点
- 四种大体亚型3年总生存率分别为I型91%、II型80%、III型74.6%、IV型38.8%。
- IV型在全队列和IPTW队列中均与不良预后独立相关。
- IV型肝癌患者可能从辅助动脉内治疗中获益,而其他三型则不然。
核心结论
- 不同大体类型的肝细胞癌表现出显著不同的预后和分子特征。
- 大体分类可能有助于为肝细胞癌制定精准个体化诊断和治疗策略。
研究设计与样本
- 前瞻性队列纳入400例接受肝切除术的单发肝细胞癌患者,评估大体分类。
- 对49例患者的肿瘤及非肿瘤组织进行多组学分析以探究大体分类的机制。
- 采用逆概率处理加权(IPTW)控制混杂因素。
主要发现
- 四种大体亚型3年总生存率分别为I型91%、II型80%、III型74.6%、IV型38.8%。
- IV型在全队列和IPTW队列中均与不良预后独立相关。
- 四种大体亚型呈现三个不同的转录模块。
- IV型肿瘤表现为血管生成和免疫评分增高、代谢通路降低,并伴有最高频率的TP53突变。
- IV型肝细胞癌患者可能从辅助动脉内治疗中获益,而其他三型则不然。
关键数值与推荐
- 据此建立了改良的三分法边缘形态大体分类。
临床怎么用
- 大体分类可能有助于为肝细胞癌制定精准个体化诊断和治疗策略。
- IV型肝细胞癌患者可能从辅助动脉内治疗中获益,而其他三型则不然。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Selecting interventions for patients with solitary hepatocellular carcinoma (HCC) remains a challenge. Despite gross classification being proposed as a potential prognostic predictor, its widespread use has been restricted due to inadequate studies with sufficient patient numbers and the lack of established mechanisms. We sought to investigate the prognostic impacts on patients with HCC of different gross subtypes and assess their corresponding molecular landscapes. DESIGN: A prospective cohort of 400 patients who underwent hepatic resection for solitary HCC was reviewed and analysed and gross classification was assessed. Multiomics analyses were performed on tumours and non-tumour tissues from 49 patients to investigate the mechanisms underlying gross classification. Inverse probability of treatment weight (IPTW) was used to control for confounding factors. RESULTS: Overall 3-year survival rates varied significantly among the four gross subtypes (type I: 91%, type II: 80%, type III: 74.6%, type IV: 38.8%). Type IV was found to be independently associated with poor prognosis in both the entire cohort and the IPTW cohort. The four gross subtypes exhibited three distinct transcriptional modules. Particularly, type IV tumours exhibited increased angiogenesis and immune score as well as decreased metabolic pathways, together with highest frequency of TP53 mutations. Patients with type IV HCC may benefit from adjuvant intra-arterial therapy other than the other three subtypes. Accordingly, a modified trichotomous margin morphological gross classification was established. CONCLUSION: Different gross types of HCC showed significantly different prognosis and molecular characteristics. Gross classification may aid in development of precise individualised diagnosis and treatment strategies for HCC.
引用
- Fan Z, Jin M, Zhang L, et al. From clinical variables to multiomics analysis: a margin morphology-based gross classification system for hepatocellular carcinoma stratification. Gut. 2023. PMID: 37549980. doi:10.1136/gutjnl-2023-330461
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。